Lise M. B. Fjellsbø

Toxic effects of gunshot fumes from different ammunitions for small arms on lung cells exposed at the air liquid interface

Mariussen, Espen; Fjellbø, Lise Marie; Frømyr, Tomas Roll; Johnsen, Ida Vaa; Karsrud, Tove Engen; Voie, Øyvind Albert

Application of the comet assay in nanotoxicology.

Dusinska, M.; Rundén-Pran, E.; El Yamani, N.; Fjellsbø, L. M.; Collins, A.

Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles.

Gabelova, A.; El Yamani, N.; Alonso, T.I.; Buliakova, B.; Srancikova, A.; Babelova, A.; Rundén-Pran, E.; Fjellsbø, L.M.; Elje, E.; Yazdani, M.; Silva, M.J.; Dusinska, M.

Comparison of in vitro human cytotoxicity assays in relation to genotoxicity testing of nanomaterials.

Rundén-Pran, E.; El Yamani, N.; Fjellsbø, L. M.; Dusinska. M.

Nanoparticles: a hidden hazard?

Dusinska, M.; El Yamani, N.; Gabelova, A.; Alonso T. I.; Rundén-Pran, E.; Fjellsbø, L. M.; Silva, M. J.; Shaposhnikov, S.; Collins, A. R.

Mutagenic and carcinogenic potential of metal nanoparticles depends on physicochemical properties.

Dusinska, M.; El Yamani, N.; Fjellsbø, L. M.; Huk, A.; Gabelova, A.; Rundén-Pran, E.

Comparison of in vitro human cytotoxicity assays in relation to genotoxicity testing of nanomaterials.

Rundén-Pran, E.; El Yamani, N.; Fjellsbø, L. M.; Dusinska, M.

Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST.

Dusinska, M.; Boland, S.; Saunders, M.; Juillerat-Jeanneret, L.; Tran, L.; Pojana, G.; Marcomini, A.; Volkovova, K.; Tulinska, J.; Knudsen, L.E.; Gombau, L.; Whelan, M.; Collins, A.R.; Marano, F,, Housiadas, C.; Bilanicova, D.; Kenzaoui, B.H.; Carreira, S.C.; Magdolenova, Z.; Fjellsbø, L.; Huk, A.; Handy, R.; Walker, L.; Barancokova, M.; Bartonova, A.; Burello, E.; Castell, J.; Cowie, H.; Drlickova, M.; Guadagnini, R.; Harris, H.; Harju, M.; Heimstad, E.S.; Hurbankova, M.; Kazimirova, A.; Kovacikova, Z.; Kuricova, M.; Liskova, A.; Milcamps, A.; Neubauerova, E.; Palosaari, T.; Papazafiri, P.; Pilou, M.; Poulsen, M.S.; Ross, B.; Rundén-Pran, E.; Sebekova, K.; Staruchova, M.; Vallotto, D.; Worth, A.

Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles.

Magdolenova, Z.; Drlickova, M.; Henjum, K.; Rundén-Pran, E.; Tulinska, J.; Bilanicova, D.; Pojana, G.; Kazimirova, A.; Barancokova, M.; Kuricova, M.; Liskova, A.; Staruchova, M.; Ciampor, F.; Vavra, I.; Lorenzo, Y.; Collins, A.; Rinna, A.; Fjellsbø, L.; Volkovova, K.; Marcomini, A.; Amiry-Moghaddam, M.; Dusinska, M.

Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project.

Juillerat, L.; Fjellsbø, L.M.; Dusinska, M.; Collins, A.R.; Handy, R.; Riediker, M.; the NanoTEST Consortium.

Genotoxic and mutagenic potential of nitramines.

Fjellsbø, L.M.; Verstraelen, S.; Kazimirova, A.; Van Rompay, A.R.; Magdolenova, Z.; Dusinska, M.

Toxicological aspects for nanomaterial in humans.

Dusinska, M.; Magdolenova, Z.; Fjellsbøe, L.M.

Silver nanoparticles induce premutagenic DNA oxidation that can be prevented by phytochemicals from Gentiana asclepiadea.

Hudecova, A.; Kusznierewicz, B.; Rundén-Pran, E.; Magdolenova, Z.; Hasplova, K.; Rinna, A.; Fjellsbø, L.M.; Kruszewski, M.; Lankoff, A.; Sandberg, W.J.; Refsnes, M.; Skuland, T.; Schwarze, P.; Brunborg, G.; Bjøras, M.; Collins, A.; Miadoková, E.; Galova, E.; Dusinska, M.

Alternative approaches to standard toxicity testing. TQP ID 9-OPTION-257430181-NILU.

Harju, M.; Ravnum, S.; Rundén-Pran, E.; Grossberndt, S.; Fjellsbø, L.M.; Dusinska, M.; Heimstad, E.S.

Toxicity of silver nanomaterials in higher eukaryotes.

Kruszewski, M.; Brzoska, K.; Brunborg, G.; Asare, N.; Dobrzynska, M.; Dusinska, M.; Fjellsbø, L.M.; Georgantzopoulou, A.; Gromadzka-Ostrowska, J.; Gutleb, A.C.; Lankoff, A.; Magdolenova, Z.; Rundén-Pran, E.; Rinna, A.; Instanes, C.; Sandberg, W.J.; Schwarze, P.; Stepkowski, T.; Wojewódzka, M.; Refsnes, M.

Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.

Bouwmeester, H.; Lynch, I.; Marvin, H.J.P.; Dawson, K.A.; Berges, M.; Braguer, D.; Byrne, H.J.; Casey, A.; Chambers, G.; Clift, M.J.D.; Elia, G.; Fernandes, T.F.; Fjellsbø, L.B.; Hatto, P.; Juillerat, L.; Klein, C.; Kreyling, W.G.; Nickel, C.; Riediker, M.; Stone, V.

Safety assessment of nanoparticles cytotoxicity and genotoxicity of metal nanoparticles in vitro.

Magdolenova, Z.; Rinna, A.; Fjellsbø, L.; Dusinska, M.

MAPK pathways activation induced by nanosilver and TiO2: Role of Ros.

Rinna, A.; Magdolenova, Z. Fjellsbø, L.; Dusinska, M.

Coordinated approach to improved environmental genotoxicity testing: EceGenoTox.

Shaposhnikov, S.; Brunborg, G.; Collins, A.R.; Dusinska, M.; Azqueta, A.; Fjellsbø, L.

Effect of nanosilver and TiO2 on MAPK activation: role of ROS and implicaton of DNA damage.

Rinna, A.; Magdolenova, Z.; Hudecová, A.; Hasplová, K.; Fjellsbø, L.; Dusinska, M.

Assessment of potential protective effect of plant extracts from Papaver rhoeas and Gentiana asclepiadea on mammalian cells.

Hasplova, K.; Hudecová, A.; Magdalenova, Z.; Rinna, A.; Fjellsbø, L.; Miadoková, E.; Gálová, E.; Eliska, V.; Dusinska, M.

Contralateral breast doses measured by film dosimetry: tangential techniques and an optimized IMRT technique.

Saur, S.; Fjellsbø, L.M.B.; Lindmo, T.; Frengen, J.

Nanogenotoxicology. Application of the comet assay in genotoxicity testing of nanomaterials.

Dusinska, M.; Magdolenova, Z.; Fjellsbø, L.M.; Hudecova, A.; Hasplova, K.; Rinna, A.; Rundén-Pran, E.

Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics.

Dusinska, M.; Fjellsbø, L.M.; Tran, L.; Juillerat-Jeanneret, L.; Marano, F.; Boland, S.; Saunders, M.; Whelan, M.; Housiadas, C.; Volkovova, K.; Tulinska, J.; Knudsen, L.E.; Vilà, M.; Gombau, L.; Pojana, G.; Macromini, A.

Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project.

Dusinska, M.; Fjellsbø, L.M.; Heimstad, E.S.; Harju, M.; Bartonova, A.; Tran, L.; Juillerat-Jeanneret, L.; Halamoda, B.; Mranao, F.; Boland, S.; Saunders, M.; Cartwright, L.; Carreira, S.; Thawley, S.; Whelan, M.; Klein, C.; Housiadas, C.; Volkonova, K.; Tulinska, J.; Beno, M.; Sebekova, K.; Knudsen, L.E.; Mose, T.; Castell, J.V.; Vilà, M.R.; Gombau, L.; Jepson, M.; Pojana, G.; Marcomini, A.

Impact of nanomaterials on human health: lessons from in vitro and animal models.

Magdolenova, Z.; Dusinska, M.; Fjellsbø, L.M.; Schwarze, P.; Brunborg, G.; Wojewódzka, M.; Dobrzynska, M.; Gromadzka, J.; Lankoff, A.; Instanes, C.; Refsnes, M.; Låg, M.; Rundén-Pran, E.; Kruszewski, M.

Health impacts and air pollution – An exploration of factors influencing estimates of air pollution impact upon the health of European citizens.

Barrett, K.; de Leeuw, F.; Fiala, J.; Larssen, S.; Sundvor, I.; Fjellsbø, L.; Dusinska, M.; Ostatnicka, J.; Horalek, J.; Cernikovsky, L.; Barmpas, F.; Moussipoulos, N.; Vlahocostas, C.